Kamyar Kalantar-Zadeh M.D. to Bone Density Conservation Agents
This is a "connection" page, showing publications Kamyar Kalantar-Zadeh M.D. has written about Bone Density Conservation Agents.
Connection Strength
1.073
-
Administered paricalcitol dose and survival in hemodialysis patients: a marginal structural model analysis. Pharmacoepidemiol Drug Saf. 2012 Nov; 21(11):1232-9.
Score: 0.399
-
Outcomes associated with phosphorus binders in men with non-dialysis-dependent CKD. Am J Kidney Dis. 2010 Nov; 56(5):842-51.
Score: 0.345
-
Management of mineral and bone disorder after kidney transplantation. Curr Opin Nephrol Hypertens. 2012 Jul; 21(4):389-403.
Score: 0.098
-
Association of cumulatively low or high serum calcium levels with mortality in long-term hemodialysis patients. Am J Nephrol. 2010; 32(5):403-13.
Score: 0.087
-
Bone and mineral disorders in pre-dialysis CKD. Int Urol Nephrol. 2008; 40(2):427-40.
Score: 0.072
-
Battleground: chronic kidney disorders mineral and bone disease--calcium obsession, vitamin d, and binder confusion. Clin J Am Soc Nephrol. 2008 Jan; 3(1):168-73.
Score: 0.071